Devic's Disease
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Autologous Transplant To End NMO Spectrum Disorder (NCT03829566) | Northwestern University | 2019-11-01 |
| A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD (NCT03062579) | Fu-Dong Shi | 2017-02-01 |
| Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders (NCT02249676) | Tianjin Medical University General Hospital | 2013-01-01 |
| Hematopoietic Stem Cell Transplant in Devic's Disease (NCT00787722) | Northwestern University | 2009-10-10 |
| An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica (NCT00904826) | Mayo Clinic | 2009-04-01 |
Track Devic's Disease automatically
Every clearance here is in the API, with alerts when new ones post.